secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2023-01-18T23:59:59+00:00
Accession:  0001493152-23-001789
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma raises CSO Kishor Bhatia's base salary to $235,000 effective Jan 2023
--------------------------------------------------------------------------------

- Board approved amendment to employment agreement increasing annual base salary to $235,000.
- Increase takes effect with the first pay period in January 2023.
- Dr. Bhatia continues as Chief Scientific Officer of Lantern Pharma.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223001789/0001493152-23-001789-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223001789/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-001789

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer